Plectin in skin fragility disorders
Abstract: Plectin is a multi-faceted, 500 kDa-large protein, which due to its expression in different isoforms and distinct organs acts diversely as a cytoskeletal crosslinker and signaling scaffold. It functions as a mediator of keratinocyte mechanical stability in the skin, primarily through linking intermediate filaments to hemidesmosomes. Skin fragility may occur through the presence of mutations in the gene encoding for plectin, PLEC, or through the presence of autoantibodies against the molecule. Below, we review the cutaneous manifestations of plectinopathies as well as their systemic involvement in specific disease subtypes. We summarize the known roles of plectin in keratinocytes and fibroblasts and provide an outlook on future perspectives for plectin-associated skin disorders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Cells. - 10, 10 (2021) , 2738, ISSN: 2073-4409
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2021
- Urheber
- DOI
-
10.3390/cells10102738
- URN
-
urn:nbn:de:bsz:25-freidok-2223411
- Rechteinformation
-
Kein Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:46 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kiritsi, Dimitra
- Tsakiris, Leonidas
- Schauer, Franziska
- Universität
Entstanden
- 2021
Ähnliche Objekte (12)
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Recent advances in understanding and managing epidermolysis bullosa
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Autologous skin micro-grafts and allogenic skin allograft for mitten hand deformity treatment in epidermolysis bullosa
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study
Skin fragility: perspectives on evidence-based therapies
Inborn errors of immunity and immunodeficiencies: antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Recent advances in understanding and managing epidermolysis bullosa
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Autologous skin micro-grafts and allogenic skin allograft for mitten hand deformity treatment in epidermolysis bullosa
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study
Skin fragility: perspectives on evidence-based therapies
Inborn errors of immunity and immunodeficiencies: antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions
Dupilumab improves itch and blistering in different subtypes of epidermolysis bullosa
Postzygotic mosaicism in genetic skin disorders : causes and pathogenetic mechanisms
Transmembrane collagens - unexplored mediators of epidermal‐dermal communication and tissue homeostasis
Systemic retinoids for treatment of recalcitrant IgA pemphigus
Recent advances in understanding and managing epidermolysis bullosa
Towards a roadmap for COSEB: the next steps in harmonization of outcomes for epidermolysis bullosa
Dystrophic epidermolysis bullosa: secondary disease mechanisms and disease modifiers
Case report: minimal manifestations of mucous membrane pemphigoid in a young adult
Autologous skin micro-grafts and allogenic skin allograft for mitten hand deformity treatment in epidermolysis bullosa
Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large prospective cohort study
Skin fragility: perspectives on evidence-based therapies
Inborn errors of immunity and immunodeficiencies: antibody‐mediated pathology and autoimmunity as a consequence of impaired immune reactions